Email this article 
Le pictogramme de la fatigue : évaluation psychométrique d’un nouvel outil clinique
Abstract
La fatigue est un des effets secondaires du cancer les plus courants, et pourtant les cliniciens y accordent généralement peu d’attention dans le cadre des rendez-vous cliniques souvent fort chargés. Ce projet visait à évaluer les propriétés psychométriques d’un nouvel instrument à deux éléments conçu pour identifier rapidement les patients qui éprouvent des difficultés liées à la fatigue. Nous avons réalisé l’évaluation auprès de 190 patients atteints d’un cancer du poumon et traités dans des cliniques ambulatoires. Le pictogramme de la fatigue a affiché une bonne fiabilité de test-retest sur une période de 24 heures (coefficients kappa pondérés de 0,71 pour la première question et de 0,72 pour la seconde) et sur le plan de l’équivalence des méthodes (en personne et au téléphone) (coefficients kappa pondérés de 0,64 pour la première question et de 0,65 pour la seconde). Nous avons évalué la validité en comparant les résultats du nouvel outil avec l’inventaire multidimensionnel de la fatigue et le questionnaire SF-36. Dans l’ensemble, les patients qui affichaient des niveaux de fatigue élevés ont indiqué des niveaux élevés sur toutes les échelles respectives.
Le nouveau pictogramme de la fatigue était facile à administrer et à coter dans un milieu clinique fort occupé. Il fournit un instrument standardisé fiable et valide permettant d’identifier les patients qui éprouvent des difficultés liées à la fatigu.
Full Text:
PDFReferences
Ahlberg, K., Ekman, T., Gaston-Johansson, F., & Mock, V. (2003).
Assessment and management of cancer-related fatigue in adults.
Lancet, 362(9384), 640–50.
Ancoli-Israel, S., Liu, L., Marler, M., Parker, B., Jones, B., Sadler, G., …
Fiorentino, L. (2006). Fatigue, sleep and circadian rhythms prior to
chemotherapy for breast cancer. Supportive Cancer in Care, 14(3),
–209.
Berglund, G., Bolund, C., Fornander, T., Rutqvist, L.E., & Sjoden, P.
(1991). Late effects of adjuvant chemotherapy and post operative
radiotherapy on quality of life among breast cancer patients.
European Journal of Cancer, 27(9), 1075–1081.
Cella, D. (1997). The Functional Assessment of Cancer Therapy Anemia
(FACT-AN) Scale: A new tool for the assessment of outcomes in
cancer anemia. Seminars in Haematolology, 34(3, Suppl. 2), 13–19.
Cella, D., Lai, J.S., Chang, C.H., Peterman, A., & Slavin, M. (2002).
Fatigue in cancer patients compared with fatigue in the general
United States population. Cancer 94(2), 528–538.
Chan, C.W., & Molassiotis, A. (2001). The impact of fatigue on
Chinese cancer patients in Hong Kong. Supportive Care in
Cancer, 9(1), 18–24.
Cleeland, C.S. (2001). Cancer-related fatigue: New directions for
research (introduction). Cancer, 92(6 Suppl.), 1657–1661.
Curt, G.A., & Johnson, P.G. (2003). Cancer fatigue: The way forward.
Oncologist, 8(Suppl. 1), 27–30.
Danjoux, C., Gardner, S., & Fitch, M.I. (2007). Prospective evaluation
of fatigue during a course of curative radiotherapy for localized
prostate cancer. Supportive Care in Cancer, 15(1), 1169–1176.
Davis, K.M., Lai, J., Hahn, E.A., & Cella, D. (2008). Conducting routine
fatigue assessment for use in oncology practice: Patient and
provider perspective. Supportive Care in Cancer, 16(4), 379–386.
Fitch, M.I. (2010). Supportive care needs of patients with advanced
disease undergoing radiotherapy for symptom control.
Manuscript accepted for publication.
Fitch, M.I., & Steele, R. (2010). Supportive care needs of individuals with
lung cancer. Canadian Oncology Nursing Journal, 20(1), 15–22.
Fitch, M., Gowing, J., Murray, A., McKillop, I., Schertzer, L., & Deane,
K. (2002). Measuring supportive care needs over time: How well
are we doing?†Supportive Care in Cancer, 10.
Irvine, D., Vincent, L., Grayson, J.E., Bubela, N., & Thompson, L.
(1994). The prevalence and correlates of fatigue in patients
receiving treatment with chemotherapy and radiotherapy: A
comparison with the fatigue experienced by healthy individuals.
Cancer Nursing, 17(5), 367–378.
Mitchell, S., Beck, S.L., Hood, L.E., Moore, K., & Tanner, E.R. (2007).
Putting evidence into practice: Evidence-based interventions for
fatigue during and following cancer and its treatment. Clinical
Journal of Oncology Nursing, 11(1), 99–113.
National Comprehensive Cancer Network. (2007). NCCN Guidelines
for Supportive Care. Retrieved from http://www.nccn.org/
professionals/physician_gls/PDF/fatigue.pdf
Nunnally, J.C., & Bernstein, I. (1994). Psychometric theory. Toronto,
ON: McGraw-Hill.
Olson, K. (2007). A new way of thinking about fatigue—A
reconceptualization. Oncology Nursing Forum, 34(1), 90–93.
Olson, K., Krawchuk, A., & Qudussi, T. (2007). Fatigue in individuals
with advanced cancer in active treatment and palliative settings.
Cancer Nurse, 30(6), 1–10.
Piper, B.F. (1990). Piper fatigue scale available for clinical testing.
Oncology Nursing Forum, 17(5), 661–662.
Portenoy, R.K., & Itri, L.M. (1999). Cancer-related fatigue: Guidelines
for evaluation and management. Oncologist, 4(1) 1–10.
Ream, E., Richardson, A., & Alexander-Dann, C. (2006). Supportive
intervention for fatigue in patients undergoing chemotherapy:
A randomized controlled trial. Journal of Pain & Symptom
Management, 31(2), 148–61.
Servaes, P.F., Verhagen, C.F., & Bleijenberg, G. (2002). Fatigue in
cancer patients during and after treatment: Prevalence, correlates
and interventions. European Journal of Cancer, 38(1), 27–43.
Smets, E.M.A., Garssen, B., Cull, A., & deHaes, J.C.J.M. (1996).
Application of the multidimensional fatigue inventory (MFI-20) in
cancer patients receiving radiotherapy. British Journal of Cancer,
(2), 241–245.
Steele, R., & Fitch, M.I. (2008). Supportive care needs of women with
gynecological cancer. Cancer Nursing, 31(4), 284–291.
Tiesinga, L.J., Dassen, T.W.N., & Halfens, R.J.G. (1996). Fatigue—A
summary of the definitions, dimensions and indicators. Nursing
Diagnosis, 7(2), 51–62.
Vogelzang, N.J., Breitbart, W., Cella, D., Curt, G.A., Groopman, J.E.,
Herning, S.J., … Portenoy, R.K. (1997). Patient caregiver and
oncologist perspectives of cancer-related fatigue: Results of a
tripartite assessment survey: The Fatigue Coalition. Seminars in
Haematology, 34(3, Suppl. 2), 4–12.
Ware, J.E. Jr., & Sherbourne, C.D. (1992). The MOS 36-item shortform
health survey (SF-36). I. Conceptual framework and item
selection. Medical Care, 30(6), 473–483.
Wei, J.T., Dunn, R.L., Sandler, H.M., McLaughlin, P.W. Montie, J.E., Litwin,
N.S., … Sanda, M.G. (2002). Comprehensive comparison of healthrelated
quality of life after contemporary therapies for localized
prostate cancer. Journal of Clinical Oncology, 20(2), 557–66.
Windsor, P.M., Nicol, K.F., & Poller, J. (2004). A randomized
controlled trial of aerobic exercise for treatment-related fatigue
in men receiving radical external beam radiotherapy for localized
prostate carcinoma. Cancer, 101(3), 550–57.
Winningham, M.L., Nail, L.M., Burke M.B., Brophy, L., Cimprich, B.,
Jones, L.S., et al. (1994). Fatigue and the cancer experience: The
state of the knowledge. Oncology Nursing Forum, 21(1), 23–35.
Wu, H.S., & McSweeney, M. (2004). Assessing fatigue in persons with
cancer: An instrument development and testing study. Cancer,
(7), 1685–95.
Yellen, S.B., Cella, D.F., Webster, K., Blendowski, C., & Kaplan, E.
(1997). Measuring fatigue and other anemia-related symptoms
with the Functional Assessment of Cancer Therapy (FACT)
Measurement System. Journal of Pain & Symptom Management,
(2), 63–74.
Zubrod, C.G., Schneiderman, M., Frei, E., Brindley, C., Gold, G.L.,
Snider, B., et al. (1960). Appraisal of methods for study of
chemotherapy of cancer in man. Journal of Chronic Diseases,
(1), 7–33.
Refbacks
- There are currently no refbacks.
